Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease |
| |
Authors: | Maria Teresa Arias-Loste Geovana Bonilla Irene Moraleja Michael Mahler Miguel Angel Mieses Beatriz Castro Montserrat Rivero Javier Crespo Marcos López-Hoyos |
| |
Institution: | 1. Gastroenterology and Hepatology Department, Marques de Valdecilla University Hospital-IFIMAV, Santander, Spain 2. Immunology Department, Marques de Valdecilla University Hospital-IFIMAV, Santander, Spain 3. Research and Development, INOVA Diagnostics, San Diego, CA, USA 4. Servicio Inmunología, Hospital Universitario Marqués de Valdecilla, 39008, Santander, Spain
|
| |
Abstract: | Anti-proteinase 3 anti-neutrophil cytoplasmic antibodies (anti-PR3 ANCA) represent an established serologic marker of active granulomatosis with polyangiitis, but their role as a serologic marker in inflammatory bowel disease (IBD) remains uncertain. This study evaluates the presence of anti-PR3 ANCA and their validity as a serologic marker to aid in the diagnosis of IBD. Retrospectively, 142 serum samples obtained at early stages of the disease were analyzed with a new chemiluminiscent assay for the measurement of anti-PR3 ANCA. The results were correlated to the diagnosis, clinical, and therapeutic data, and ANCA and anti-Saccharomyces cerevisiae antibody (ASCA) measurements available from routine clinical practice. Anti-PR3 ANCA were significantly more prevalent (p?<?0.0001) and their titers significantly higher (p?<?0.0001) among ulcerative colitis compared with Crohn’s disease patients. Receiver operating characteristic curve analysis performed with anti-PR3 ANCA titers to assess the diagnostic accuracy of the assay gave an area under the curve of 0.81 (95 % CI (0.76–0.89); p?<?0.0001), with a cut-off titer of 11.8 chemiluminescent units displaying 52.1 % sensitivity and 97.3 % specificity for ulcerative colitis. Combining anti-PR3 ANCA positivity with IgA ASCA negativity as the diagnostic parameter demonstrated highest diagnostic utility, with a sensitivity and specificity of 47.5 % and 98.2 %, respectively. In our cohort, anti-PR3 ANCA was significantly more prevalent in ulcerative colitis than in Crohn’s disease patients, which suggests a possible role of anti-PR3 ANCA as a serologic marker to aid in the diagnosis of IBD. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|